Order Detail

Order In the Matter of Second Phase review acquisition of the Global Vaccines business (excluding influenza vaccines business except in China) from Novartis A.G by Glaxosmithkline PLC 20-02-2015
Brief Description
Section 11
Violation: Second Phase Review (favorable order with condition)
Sector: Pharmaceutical
Penalty: No Penalty
Adjudicating Members
Ms. Vadiyya Khalil Dr. Joseph Wilson Dr. Shahzad Ansar Mr. Mueen Batlay Mr. Ikram UI Haque Qureshi

© CCP 2024, Competition Commission of Pakistan ©All rights reserved